Clinical Trial Update: Biomarker Study in Participants With Migraine [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 biomarker study in participants with migraine completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine Disorders | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-02-26